Skip to main content

Patient guide · Tests & Procedures

Lymph node biopsy, ultrasound-guided core biopsy or excisional biopsy of enlarged lymph nodes.

Lymph node biopsy takes tissue for histology from an enlarged or suspicious node. Modern options: ultrasound-guided core biopsy, FNA, or excisional biopsy — for lymphoma diagnosis, metastatic staging, sarcoidosis and infection.

Read the key facts
An interventional radiologist performing an ultrasound-guided lymph node biopsy in a private London clinic

Why patients choose us

  • 01

    The right hands

    We route you to a consultant interventional radiologist or head-and-neck surgeon — whoever your case actually needs.

  • 02

    Right technique, first time

    Core biopsy, FNA or excisional — chosen for the clinical question, not for what the clinic happens to offer.

  • 03

    Independent, and free

    We are paid by no clinic, so the recommendation is impartial and costs you nothing.

Key facts

What every patient should know about lymph node biopsy.

A quick orientation to the technique, the choice between core and excisional biopsy, and how the tissue is handled.

  • What it is

    A biopsy of an enlarged or suspicious lymph node — sampling tissue for histology.

  • US-guided core biopsy

    Often first-line: image-guided cores from a palpable or ultrasound-visible node.

  • Excisional biopsy

    For suspected lymphoma — nodal architecture matters for accurate subtyping.

  • FNA

    Fine-needle aspiration is a screening tool for metastatic disease from a known primary.

  • Local anaesthetic day-case

    Performed under LA in a day-case setting — home the same afternoon.

  • Handled for full work-up

    Sample split for histology, flow cytometry and molecular tests where lymphoma is on the differential.

How it’s done

From consultation to histology — step by step.

The path from first appointment to the pathologist’s report. Most patients are home the same afternoon.

  1. 01

    Consultation and imaging

    Review of history, examination and existing ultrasound, CT or PET-CT.

  2. 02

    Coagulation check

    Recent bloods (FBC, clotting) and a review of anticoagulant or antiplatelet medication.

  3. 03

    Local anaesthetic

    Skin and track infiltrated with lidocaine — the procedure itself is not painful.

  4. 04

    US-guided needle placement

    Real-time ultrasound guides the needle to the target node, away from vessels and nerves.

  5. 05

    Multiple cores taken

    Several passes with a core-biopsy device — usually three to five cores for adequate tissue.

  6. 06

    Excisional if lymphoma suspected

    If lymphoma is on the differential, an intact node is removed surgically to preserve architecture.

  7. 07

    Histology in 7–14 days

    Reported by a specialist haematopathologist, with immunohistochemistry and molecular add-ons.

What it shows

The diagnoses a lymph node biopsy can confirm.

From the benign and reassuring to the diagnoses that trigger a specialist pathway — the biopsy tells the story.

  • Reactive lymphadenopathy

    Benign, infection-driven node enlargement — the most common answer.

  • Hodgkin lymphoma

    Classical or nodular lymphocyte-predominant subtypes, staged and treated by haematology.

  • Non-Hodgkin lymphoma

    Wide range of B- and T-cell lymphomas — subtype drives the treatment plan.

  • Metastatic carcinoma

    Nodal spread from a known or occult primary — head-and-neck, breast, lung, GI.

  • Sarcoidosis granulomas

    Non-caseating granulomas — the tissue diagnosis that unlocks the sarcoidosis pathway.

  • TB granulomas

    Caseating granulomas with special stains and TB culture where indicated.

  • Castleman disease

    Rare lymphoproliferative disorder — unicentric or multicentric variants.

  • Red flag: high-grade lymphoma — urgent haematology MDT

    Aggressive histology triggers same-week haematology review and staging.

Treatment options

What happens after the diagnosis is made.

Every biopsy result — reactive, malignant or granulomatous — has a defined next step. These are the main pathways.

  • Reassurance for reactive nodes

    Benign histology, with a plan for re-imaging if the node does not settle.

  • Haematology / oncology MDT

    A malignant diagnosis is routed straight into the appropriate specialist MDT.

  • Chemotherapy / immunotherapy

    The mainstay of treatment for most lymphomas and disseminated metastatic disease.

  • Radiotherapy for early-stage Hodgkin

    Combined-modality treatment for limited-stage classical Hodgkin lymphoma.

  • Sarcoidosis treatment (steroids)

    Corticosteroids where organ involvement or symptoms justify treatment.

  • TB pathway

    Referral to the local TB service for standard anti-tuberculous therapy and contact tracing.

  • Antibiotics for infection

    Targeted antibiotics where a specific infective cause is identified.

  • Structured follow-up

    Clinical and imaging surveillance to confirm resolution or detect recurrence.

Red flags

When lymphadenopathy needs urgent attention.

Scenarios where the pathway is expedited or handed to a specialist MDT the same week.

  • High-grade lymphoma

    Diffuse large B-cell and other aggressive subtypes — urgent haematology input.

  • Metastatic SCC (head-and-neck)

    Squamous cell carcinoma in a neck node triggers head-and-neck MDT and primary search.

  • Rapidly growing node

    Rapid, painless enlargement over weeks warrants urgent tissue diagnosis.

  • Constitutional symptoms (B symptoms)

    Fever, drenching night sweats or weight loss raise suspicion of lymphoma.

  • HIV-related lymphadenopathy

    A distinct differential including HIV-associated lymphoma and opportunistic infection.

  • Post-transplant lymphoproliferative disease

    EBV-driven proliferation in transplant recipients — treated by the transplant team.

  • TB with drug resistance

    Positive TB with resistance requires specialist infection input and public-health notification.

  • Suspected sarcoma metastasis

    Nodal spread from soft-tissue or bone sarcoma — sarcoma MDT pathway.

  • Kikuchi disease differential

    Rare histiocytic necrotising lymphadenitis — usually self-limiting, avoids overtreatment.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Cover depends on your policy and clinic; we confirm with your insurer before booking.

Frequently asked

Everything we get asked about lymph node biopsy.

Quick answers on core vs excisional biopsy, FNA, pain, results and when the pathway becomes urgent.

  • What does a lymph node biopsy show?

    Whether an enlarged node is reactive (benign), infective (such as TB), granulomatous (such as sarcoidosis), or malignant (lymphoma or metastatic cancer). The pathologist reports cell type, immunohistochemistry and, where relevant, molecular findings.

  • Core biopsy or excisional biopsy — which is right?

    Ultrasound-guided core biopsy is often first-line and answers most metastatic questions. If lymphoma is on the differential, an excisional (whole-node) biopsy is preferred because lymphoma subtyping depends on preserved nodal architecture.

  • What is an FNA and when is it used?

    Fine-needle aspiration collects cells rather than tissue cores. It is a good screening tool for metastatic carcinoma from a known primary, but it is rarely sufficient to diagnose or subtype lymphoma.

  • Is a lymph node biopsy painful?

    The skin and track are infiltrated with local anaesthetic, so the procedure itself feels like pressure rather than pain. Excisional biopsy is done under local or general anaesthetic depending on site and patient preference.

  • How long do results take?

    Core-biopsy histology is typically reported within 7–14 days, with molecular and immunohistochemistry add-ons taking a little longer. Urgent cases are expedited by the pathology team.

  • When should I see a doctor urgently?

    Rapidly enlarging, painless nodes — especially with fever, drenching night sweats or weight loss — need urgent assessment under the two-week-wait pathway. Any sudden airway symptoms are an emergency.

WhatsApp Call us

In practice, in London

Why private lymph node biopsy moves differently in London

With lymph node biopsy, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. Public provision for lymph node biopsy is competent but constrained by capacity. Private London clinics tend to have shorter diaries and longer appointment slots, so you get the same specialists with more time. For people who’ve been going round in circles with primary care, that first proper conversation is often what shifts things.

The mechanics are straightforward: a consultant appointment, any tests done at a nearby CQC-registered site, and a written report back within a few days. London’s density of private diagnostics — Marylebone, the City, Chelsea, Canary Wharf — means most patients can find something that fits around work without a cross-town trek. For lymph node biopsy specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.

There are a lot of consultants in London who can technically handle lymph node biopsy. Fewer who do it week in, week out for the exact question you’re bringing. We spend most of our time working out which is which — and being straight when a different test or a different specialist would serve you better. Everything runs to CQC, GMC and Royal College standards; the choice is about fit, not floor.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

Confidential. We respond within one working day.